In addition, it has been reported that obesity is characterized by reciprocal alterations in FGF19 (decrease) and FGF21 (increase) levels, and that opposite changes in β-Klotho expression in fat and the liver indicate potential tissue-specific alterations in the responsiveness to endocrine FGFs in obesity. The gene discussed is FGF21; the disease is Obesity.